CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing Cannabis Bioscience International Holdings (OTCMKTS: CBIH) proudly announces its active participation in today’s DEA meaningful hearing

Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.